Elevance Health ELV
$425.62 −$6.38 (-1.48%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $425.62 0.00%
Open$421.47
Prev close$432.00
Day range$421.47 – $430.69
Volume1.44M
Market cap$91.96B
P/E (TTM)18.1
Dividend yield1.61%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$51.43B+1.4% YoY
Net profit$1.34B+13.1% YoY
Diluted EPS$6.27+17.9% YoY
Free cash flow$1.00B+29.0% YoY
Operating cash flow$1.27B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Net margin2.5%
Return on equity11.6%
Return on assets4.1%
Liabilities / assets65.0%
Total debt$30.76B
Free cash flow / sales3.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $51.43B | $50.47B | $50.18B | $199.13B | $49.75B |
| Total Operating Revenue | $51.43B | $50.47B | $50.18B | $199.13B | $49.75B |
| Total Premiums Earned | $41.70B | $41.28B | $41.02B | $164.64B | $40.69B |
| Fee Revenue and Other Income | $8.74B | $8.55B | $8.47B | $32.95B | $8.62B |
| -Fees and Commissions | $2.28B | $2.28B | $2.25B | $8.48B | $2.16B |
| -Other Income Expense | $6.45B | $6.26B | $6.23B | $24.47B | $6.46B |
| Net Investment Income | $1.04B | $704.00M | $765.00M | $715.00M | -$986.00M |
| Net Realized Gain/Loss on Investments | -$48.00M | -$56.00M | -$78.00M | $826.00M | $1.42B |
| Total Expenses | $49.64B | $48.54B | $47.88B | $192.42B | $49.53B |
| Loss Adjustment Expense | $37.78B | $37.02B | $35.62B | $148.22B | $38.07B |
| Depreciation & Amortization | $106.00M | $110.00M | $112.00M | $628.00M | $164.00M |
| -Amortization | $106.00M | $110.00M | $112.00M | $628.00M | $164.00M |
| Net Non-Operating Interest Income (Expense) | -$358.00M | -$364.00M | -$357.00M | -$1.40B | -$366.00M |
| -Interest Expense Non-Operating | $358.00M | $364.00M | $357.00M | $1.40B | $366.00M |
| Other Operating Expenses | $11.39B | $11.04B | $11.79B | $42.16B | $10.94B |
| Pretax Profit | $1.79B | $1.94B | $2.30B | $6.71B | $215.00M |
| Tax | $451.00M | $483.00M | $544.00M | $1.05B | -$331.00M |
| Net Profit | $1.34B | $1.45B | $1.76B | $5.66B | $546.00M |
| Profit from Continuing Operations | $1.34B | $1.45B | $1.76B | $5.66B | $546.00M |
| Minority Interests | -$22.00M | -$9.00M | -$4.00M | -$1.00M | -$1.00M |
| Net Income to Parent Company | $1.37B | $1.46B | $1.76B | $5.66B | $547.00M |
| Net Income to Common Stockholders | $1.37B | $1.46B | $1.76B | $5.66B | $547.00M |
| Basic EPS | $6.30 | $6.74 | $8.03 | $25.28 | $2.48 |
| Diluted EPS | $6.27 | $6.71 | $8.00 | $25.21 | $2.47 |
| Dividend Per Share | $1.72 | $1.72 | $1.72 | $6.84 | $1.71 |
| -Net Premiums Written | – | – | – | $164.64B | – |
| Special Income (Charges) | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $127.80B | $126.44B | $125.83B | $121.49B | $121.49B |
| Cash and Cash Equivalents | $10.35B | $10.23B | $9.66B | $9.49B | $9.49B |
| Total Investments | $40.22B | $39.67B | $39.54B | $38.58B | $38.58B |
| -Short Term Investments | $25.35B | $25.72B | $25.91B | $25.88B | $25.88B |
| -Equity Investments | $3.36B | $2.82B | $2.63B | $1.86B | $1.86B |
| -Other Invested Assets | $11.51B | $11.13B | $11.01B | $10.84B | $10.84B |
| Receivables | $24.57B | $23.39B | $22.79B | $21.54B | $21.54B |
| -Accounts Receivable | $10.69B | $10.99B | $11.53B | $10.07B | $10.07B |
| -Other Receivables | $13.89B | $12.40B | $11.27B | $11.47B | $11.47B |
| Net PPE | $4.61B | $4.65B | $4.66B | $4.68B | $4.68B |
| Goodwill and Other Intangible Assets | $39.22B | $39.32B | $39.43B | $39.54B | $39.54B |
| -Goodwill | $28.34B | $28.34B | $28.34B | $28.34B | $28.34B |
| -Other Intangible Assets | $10.88B | $10.98B | $11.09B | $11.20B | $11.20B |
| Other Assets | $8.83B | $9.18B | $9.75B | $7.65B | $7.65B |
| Total Liabilities | $83.01B | $81.42B | $81.79B | $77.47B | $77.47B |
| Policy Holders Liabilities | $2.64B | $3.46B | $3.86B | $3.78B | $3.78B |
| Short-Term Debt and Capital Lease Obligation | $375.00M | $375.00M | $1.07B | $1.25B | $1.25B |
| -Current Debt | $375.00M | $375.00M | $1.07B | $1.25B | $1.25B |
| Payables | $26.75B | $25.10B | $24.63B | $24.41B | $24.41B |
| -Accounts Payable | $26.75B | $25.10B | $24.63B | $24.41B | $24.41B |
| Current Deferred Liabilities | $1.64B | $1.64B | $1.76B | $1.49B | $1.49B |
| Long Term Debt and Capital Lease Obligation | $30.38B | $30.67B | $30.77B | $30.80B | $30.80B |
| -Long Term Debt | $30.38B | $30.67B | $30.77B | $30.80B | $30.80B |
| Non-Current Deferred Liabilities | $1.49B | $2.21B | $1.79B | $2.11B | $2.11B |
| Other Liabilities | $19.74B | $17.97B | $17.91B | $13.64B | $13.64B |
| Total Equity | $44.79B | $45.02B | $44.04B | $44.03B | $44.03B |
| Stockholders' Equity | $44.68B | $44.88B | $43.90B | $43.88B | $43.88B |
| Capital Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $8.99B | $8.92B | $8.85B | $8.94B | $8.94B |
| Retained Earnings | $37.37B | $36.68B | $35.80B | $35.39B | $35.39B |
| Gains/Losses Not Affecting Retained Earnings | -$1.68B | -$711.00M | -$741.00M | -$451.00M | -$451.00M |
| Minority Interests | $113.00M | $139.00M | $140.00M | $144.00M | $144.00M |
| Assets of Discontinued Operations | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.27B | $1.91B | $4.33B | $4.29B | $84.00M |
| Net cash flow from continuing operations | $1.27B | $1.91B | $4.33B | $4.29B | $84.00M |
| Net Income from Continuing Operations | $1.34B | $1.45B | $1.76B | $5.66B | $546.00M |
| Gain/Loss from Continuing Operations | -$493.00M | -$206.00M | -$227.00M | $255.00M | -$90.00M |
| Deferred Tax | -$143.00M | $151.00M | -$274.00M | -$279.00M | -$322.00M |
| Change in Working Capital | $84.00M | $40.00M | $2.66B | -$3.28B | -$524.00M |
| -Change in Receivables | -$896.00M | -$657.00M | -$1.17B | -$2.53B | $756.00M |
| -Change in Loss and Loss Adjustment Expense Reserves | -$858.00M | -$374.00M | $1.59B | $228.00M | $1.10B |
| -Change in Payables and Accrued Expense | $1.24B | $1.24B | $2.89B | -$720.00M | -$2.26B |
| -Change in Other Current Assets | $179.00M | $111.00M | -$1.55B | $57.00M | $530.00M |
| -Change in Other Working Capital | $419.00M | -$278.00M | $910.00M | -$316.00M | -$652.00M |
| Net cash flow from investing | -$1.99B | $159.00M | -$1.64B | -$1.34B | $464.00M |
| Net Cash Flow from Continuing Investing Activities | -$1.99B | $159.00M | -$1.64B | -$1.34B | $464.00M |
| Net PPE Purchase and Sale | -$267.00M | -$287.00M | -$235.00M | -$1.12B | -$293.00M |
| Net Business Purchase and Sale | -$3.00M | $0.00 | $5.00M | $88.00M | $33.00M |
| Net Investment Purchase and Sale | -$1.49B | $276.00M | -$1.09B | $69.00M | $481.00M |
| Net Other Investing Changes | -$227.00M | $170.00M | -$323.00M | -$385.00M | $243.00M |
| Financing Cash Flow | $838.00M | -$1.49B | -$2.52B | -$1.74B | $236.00M |
| Net Cash Flow from Continuing Financing Activities | $838.00M | -$1.49B | -$2.52B | -$1.74B | $236.00M |
| Increase/Decrease in Deposit | $231.00M | -$171.00M | $313.00M | – | – |
| Net Issuance Payments of Debt | $1.28B | -$753.00M | -$1.33B | $2.33B | $1.59B |
| Net Common Stock Issuance | -$330.00M | -$234.00M | -$1.12B | -$2.61B | -$471.00M |
| Cash Dividends Paid | -$373.00M | -$373.00M | -$376.00M | -$1.53B | -$377.00M |
| Proceeds from Stock Option Exercised | $25.00M | $26.00M | $37.00M | $79.00M | $58.00M |
| Net Other Financing Charges | $4.00M | $11.00M | -$37.00M | -$10.00M | $11.00M |
| Ending Cash Balance | $10.35B | $10.23B | $9.66B | $9.49B | $9.49B |
| Net Change in Cash | $118.00M | $578.00M | $175.00M | $1.21B | $784.00M |
| Beginning Cash Balance | $10.23B | $9.66B | $9.49B | $8.29B | $8.71B |
| Effect of Exchange Rate Changes | -$2.00M | -$3.00M | -$9.00M | -$5.00M | -$6.00M |
| Free Cash Flow | $1.00B | $1.63B | $4.10B | $3.17B | -$209.00M |
No comments yet — be the first to weigh in on ELV.
Sign in to join the discussion.